Search results

519 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Alzheimer's Drug Discovery Foundation: 2017 Preclinical Drug Discovery
The Alzheimer’s Drug Discovery Foundation (ADDF) is accepting Letters of Intent (LOIs) that seek to fill the critical translational funding gap between basic research and later stage drug development by funding preclinical drug discovery and biomarker development programs relevant to Alzheimer’s disease, related dementias and cognitive aging. Award amount is up to $600,000 for one (1) year. The LOI deadline is May 19, 2017.
Located in Vital Signs / 2017 / April 27
Alzheimer's Drug Discovery Foundation, Program to Accelerate Clinical Trials
UPCOMING DEADLINE: The Alzheimer’s Drug Discovery Foundation (ADDF) is accepting Letters of Intent (LOIs) with the goal to increase the number of innovative treatments tested in humans for Alzheimer’s disease and related dementias. Award amount up to $3,000,000, based on stage and scope of research. The LOI deadline is April 13, 2018 by 5:00pm EST.
Located in Vital Signs / 2018 / April 5
Alzheimer's Drug Discovery Foundation: 2016 preclinical drug discovery RFP
The Alzheimer's Drug Discovery Foundation is accepting letters of interest for critical translational projects that bridge the gap between basic research and later-stage drug development. The Foundation is funding preclinical drug discovery and biomarker development programs relevant to Alzheimer's disease, other dementias and cognitive aging. Award amount averages up to $150,000 for one year. The submission deadline is March 4, 2016.
Located in Vital Signs / 2016 / Jan. 28
Alzheimer's Drug Discovery Foundation: 2016 Preclinical Drug Discovery RFP
The Alzheimer's Drug Discovery Foundation is accepting letters of interest that seek to fill the critical translational funding gap between basic research and later-stage drug development programs relevant to Alzheimer's disease, related dementias, and cognitive aging. Award amount is up to $600,000 for one year, though multi-year projects will be considered. Letter of interest deadline is May 13.
Located in Vital Signs / 2016 / April 7
Alzheimer's Drug Discovery Foundation offers Multiple Funding Opportunities
The Alzheimer's Drug Discovery Foundation has released several Requests for Proposals for research and clinical trial programs related to Alzheimer's disease, other dementias and cognitive aging. Letters of Intent are due June 2, 2015. Full applications are due June 16, 2015.
Located in Vital Signs / 2015 / April 16
Alzheimer's Drug Discovery Foundation: Drug Discovery Program
The Alzheimer’s Drug Discovery Foundation (ADDF) is accepting Letters of Intent (LOIs) to bridge the translational funding gap between early-stage drug discovery and clinical development for Alzheimer’s disease, related dementias and cognitive aging by supporting promising therapeutic approaches. Award amount up to $600,000. The LOI deadline is July 13, 2018.
Located in Vital Signs / 2018 / June 21
American Academy for Cerebral Palsy and Developmental Medicine: Research Grant
The American Academy for Cerebral Palsy and Developmental Medicine is accepting applications to provide seed funding to develop a high-quality clinical research project/program. The award aims to produce a competitive interdisciplinary, multi-investigator/center grant proposal for submission to larger agencies/funders of research in any area relevant to AACPDM. Award amount is up to $25,000 over 18 months. Application deadline is Sept. 30.
Located in Vital Signs / 2016 / Aug. 11
American Academy of Family Physicians Foundation: Joint Grant Awards
The AAFP Foundation is accepting applications to support research that poses important questions relevant to Family Medicine. Award amount is up to $50,000. Application deadline is July 7.
Located in Vital Signs / 2016 / March 10
American Association for Cancer Research: AACR Lymphoma Research Fellowships
UPCOMING DEADLINE: The American Association for Cancer Research (AACR) is accepting applications to support postdoctoral or clinical research fellows to conduct lymphoma research and to establish a successful career path in this field. The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to lymphoma. Fellowships will be presented in 2018 for: AACR-AstraZeneca Lymphoma Research Fellowship (two) and, AACR-Takeda Oncology Research Fellowship (one). Award amount up to $110,000 over two (2) years. The application deadline is November 16, 2017 at 1:00pm ET.
Located in Vital Signs / 2017 / Oct. 19
American Association for Cancer Research: Genentech BioOncology Fellowship for Cancer Research on the HER Family Pathway
The American Association for Cancer Research is accepting applications to support a postdoctoral or clinical research fellow conducting cancer research on the HER Family Pathway and establishing a successful career path in this field. The research proposed for funding may be basic, translational, or clinical in nature, and must have direct applicability to the HER Family Pathway in cancer. It is anticipated that one fellowship will be funded. Applicants must have a doctoral degree in a related field and not currently be a candidate for a further doctoral or professional degree. Award amount is up to $50,000 per year for up to two years. Application deadline is July 19.
Located in Vital Signs / 2016 / June 23